• Reveals fresh, ultra-smooth skin 
• Minimizes imperfections – including lines, wrinkles & enlarged pores 
• Lifts away discolorations 
• Eliminates dull skin
• Controls breakouts & clogged pores

DESCRIPTION:
Prolongs glycolic delivery into skin over a period of eight to sixteen minutes. This controlled delivery system avoids the severe spike of irritation that occurs within seconds of applying simple Glycolic Acid. Little-to-no sensations of irritation – including stinging, burning and redness – even on the first use (some sensitive skin may experience passive discomfort during the first few applications). 

To further minimize the risk of redness, tingling and stinging, REFRESH contains clinically-tested levels of soothing White Tea and Sea Whip along with a Brazilian plant complex of Kola, Mate and Guarana that is clinically-proven to reduce the irritating effects of AHAs. 

This remarkable serum is a self-preserving formula that relies on Glycolic and Lactic Acids combined with two hydrators to provide stability and protect from microbial contamination for a year or longer. 

REFRESH is developed for all skin types, even those that have been unable to use glycolic acid in the past. It is similar results as your regular AHA with less irritation.

This skin-hugging gel won’t flake, crack, peel or discolor. When stored in a cool, darkened area, the stability of this formula is guaranteed for at least one year. 

Does not contain preservatives, fragrance, colorants, oil or parabens.

PH 3.5

ACTION INGREDIENTS:

• AHA | glycolic/amino acid complex ensures maximum AHA delivery with minimum discomfort 
• Lactic Acid | lactic/amino acid complex ensures maximum AHA delivery with minimum discomfort 
• White Tea | stronger than green tea, calms signs of redness and tingling in seconds 
• Sea Whip | strongest soothing action of all sea-derived calming agents; soothes in seconds
• Kola, Mate, Guarana | Brazilian plant complex clinically-proven to reduce signs of irritation caused by AHAs 
• PEG-8/SMDI Copolymer | time-released, targeted delivery for increased AHA penetration